Hyperlipidemia News and Research

RSS
Hyperlipidemia, hyperlipoproteinemia or dyslipidemia is the presence of raised or abnormal levels of lipids and/or lipoproteins in the blood. Lipids (fatty molecules) are transported in a protein capsule, and the density of the lipids and type of protein determines the fate of the particle and its influence on metabolism.
Amgen announces results from Phase 3 TESLA Trial of evolocumab in patients with HoFH

Amgen announces results from Phase 3 TESLA Trial of evolocumab in patients with HoFH

Treatable factors linked to blood pressure variability in diabetes

Treatable factors linked to blood pressure variability in diabetes

Viewpoints: Decoupling jobs and insurance; overblown fear: Medicaid willl take my house

Viewpoints: Decoupling jobs and insurance; overblown fear: Medicaid willl take my house

Research roundup: Value-based insurance; telemedicine in nursing homes; advance care planning

Research roundup: Value-based insurance; telemedicine in nursing homes; advance care planning

Blood pressure lowering linked with reduced risk for cognitive decline in patients with T2DM

Blood pressure lowering linked with reduced risk for cognitive decline in patients with T2DM

More antipsychotic medications prescribed to children and adolescents in Germany

More antipsychotic medications prescribed to children and adolescents in Germany

ARIAD Pharmaceuticals' Iclusig now commercially available to patients in the U.S.

ARIAD Pharmaceuticals' Iclusig now commercially available to patients in the U.S.

Daiichi Sankyo submits Marketing Authorization Application for edoxaban to EMA

Daiichi Sankyo submits Marketing Authorization Application for edoxaban to EMA

Amgen reports that Phase 3 DESCARTES study for high cholesterol meets primary endpoint

Amgen reports that Phase 3 DESCARTES study for high cholesterol meets primary endpoint

Daiichi Sankyo submits LIXIANA supplemental NDA for review in Japan

Daiichi Sankyo submits LIXIANA supplemental NDA for review in Japan

Alnylam initiates Phase II study with ALN-TTRsc for treatment of ATTR

Alnylam initiates Phase II study with ALN-TTRsc for treatment of ATTR

Texas Children's Heart Center opens Center for Preventive Cardiology

Texas Children's Heart Center opens Center for Preventive Cardiology

Daiichi Sankyo presents subgroup analysis of Hokusai-VTE study at ASH annual meeting

Daiichi Sankyo presents subgroup analysis of Hokusai-VTE study at ASH annual meeting

Alnylam presents new pre-clinical data with ALN-AT3 for treatment of hemophilia and RBD

Alnylam presents new pre-clinical data with ALN-AT3 for treatment of hemophilia and RBD

Nocturia common in Japanese patients

Nocturia common in Japanese patients

Study evaluates effect of structured weight reduction program on atrial fibrillation symptoms

Study evaluates effect of structured weight reduction program on atrial fibrillation symptoms

Few newly diagnosed high-cholesterol patients get screened for thyroid dysfunction: Study

Few newly diagnosed high-cholesterol patients get screened for thyroid dysfunction: Study

Obese people experience substantial weight loss three years after bariatric surgery

Obese people experience substantial weight loss three years after bariatric surgery

Reviva announces successful completion of End-of-Phase 2 meeting for RP5063 drug

Reviva announces successful completion of End-of-Phase 2 meeting for RP5063 drug

FDA approves Clinolipid injectable emulsion for intravenous feeding in adult patients

FDA approves Clinolipid injectable emulsion for intravenous feeding in adult patients